Xilio Therapeutics (XLO) EPS (Basic) (2020 - 2026)
Xilio Therapeutics' (XLO) quarterly EPS (Basic) came in at -$0.58 in Q1 2026, up 76.71% year-on-year from -$0.33 in Q1 2025, and up 84.57% quarter-over-quarter from -$3.76 in Q4 2025.
Xilio Therapeutics (XLO) EPS (Basic) (2020 - 2026) Analysis & Trends
Xilio Therapeutics has disclosed EPS (Basic) across 7 years of filings, most recently posting -$0.58 for Q1 2026.
- EPS (Basic) for Q1 2026 came in at -$0.58, up 76.71% year-over-year; the trailing twelve-month figure through Mar 2026 was -$4.61 (up 73.32% YoY), and the FY2025 annual result was -$4.19, up 72.51% from the prior year.
- EPS (Basic) came in at -$0.58 for Q1 2026 at Xilio Therapeutics, up from -$3.76 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of -$0.11 in Q3 2025 to a low of -$14.33 in Q4 2024.
- The 5-year median for EPS (Basic) is -$0.7 (2023), against an average of -$1.68.
- Across the five-year window, EPS (Basic) jumped 97.14% in 2022 and plunged 2139.06% in 2024, its largest moves.
- Xilio Therapeutics' EPS (Basic) stood at -$0.82 in 2022, then climbed by 21.95% to -$0.64 in 2023, then tumbled by 2139.06% to -$14.33 in 2024, then soared by 73.76% to -$3.76 in 2025, then jumped by 84.57% to -$0.58 in 2026.
- The last three EPS (Basic) figures came in at -$0.58 (Q1 2026), -$3.76 (Q4 2025), and -$0.11 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -0.68 |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.06 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.00 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 0.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 0.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 4.06 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -0.06 |
| 10 | Xilio Therapeutics | 144.35 Mn | -5.95 Mn | - | -0.58 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.58 |
| Dec 31, 2025 | -3.76 |
| Sep 30, 2025 | -0.11 |
| Jun 30, 2025 | -0.16 |
| Mar 31, 2025 | -2.49 |
| Dec 31, 2024 | -14.33 |
| Sep 30, 2024 | -0.22 |
| Jun 30, 2024 | -0.24 |
| Mar 31, 2024 | -0.62 |
| Dec 31, 2023 | -0.64 |
| Sep 30, 2023 | -0.61 |
| Jun 30, 2023 | -0.70 |
| Mar 31, 2023 | -0.83 |
| Dec 31, 2022 | -0.82 |
| Sep 30, 2022 | -0.72 |
| Jun 30, 2022 | -0.90 |
| Mar 31, 2022 | -0.78 |
| Dec 31, 2021 | 62.66 |
| Sep 30, 2021 | -21.27 |
| Jun 30, 2021 | -31.48 |